1/1
Number of views:
1000

Yong Dai, Ph.D.

Founder, CEO, Frontera
Former CTO, Prevail Therapeutics
Head of CMC, uniQure
Head of Process Development Commercial Supports, Shire Pharmaceuticals
Head of ADC Process Development, ImmunoGen, Inc
Research Fellow, Molecular and Cell Biology, Harvard University
Ph.D. , Biochemistry and Molecular Biology, Chinese Academy of Sciences
Bachelor of Science, Peking University
Dr. Dai is a proven leader in biologics and gene therapy drug development. He has 20 years of industry experience in successfully building organizations and functions, developing strategy, CMC (chemistry, manufacturing, and controls), and the regulatory submissions spanning all stages of drug development.
Retail price
0.0
Market price
0.0
Number of views:
1000
Product serial number
Quantity
-
+
1
Resume description
  Ø Dr. Yong Dai, Founder, CEO, Frontera 

  Ø Former CTO, Prevail Therapeutics 

  Ø Head of CMC, uniQure 

  Ø Head of Process Development Commercial Supports, Shire Pharmaceuticals

  Ø Head of ADC Process Development, ImmunoGen, Inc 

  Ø Research Fellow, Molecular and Cell Biology, Harvard University  

  Ø Ph.D., Biochemistry and Molecular Biology, Chinese Academy of Sciences

  Ø Bachelor of Science, Peking University

Dr. Dai is a proven leader in biologics and gene therapy drug development. He has 20 years of industry experience in successfully building organizations and functions, developing strategy, CMC (chemistry, manufacturing, and controls), and the regulatory submissions spanning all stages of drug development.

 

We could not find any corresponding parameters, please add them to the properties table
Copyright ©2021-2029 Frontera Therapeutics Inc. All Rights Reserved.